FDA Approved: VORANIGO — Original Application (Servier Pharmaceuticals LLC)

View source ↗

Summary

FDA granted original approval for Voranigo (vorasidenib) by Servier Pharmaceuticals LLC for adult patients with IDH1-mutant glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• VORANIGO (VORASIDENIB)

Snippet

ORIG AP for VORANIGO (VORASIDENIB)